Understanding the precise role of LINC00501/hnRNPR/SLUG regulatory axis in advanced GC will not only expand our knowledge on the underlying mechanism of progression and metastasis of GC but also help to develop a promising biomarker and potential therapeutic target in GC. Here, SNAI2 is linked to gastric cancer.